«
»

Sprix Approved for Moderate-to-Severe Pain (HealthDay)

HealthDay – MONDAY, May 17 (HealthDay News) — Roxro Pharma’s Sprix
(ketorolac tromethamine) nasal spray has been approved by the U.S. Food
and Drug Administration for the short-term treatment of moderate to
moderately severe pain, the manufacturer said Monday in a news
release.

This entry was posted on Monday, May 17th, 2010 at 5:20 pm and is filed under Calator. You can follow any responses to this entry through the RSS 2.0 feed. Both comments and pings are currently closed.

Comments are closed.